Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Cancer. 2011 Jul 12;118(3):582–593. doi: 10.1002/cncr.26324

Table 2.

Assessment of menopausal and urinary symptoms by studies included in the systematic review

Authors Assessment of Menopausal
Symptoms
Assessment of Urinary Symptoms Prevalence/Severity of Urinary Symptoms
Alfano et al.,
200642
16 items from BCPT Symptom
Checklist
In past year, difficulty with bladder
control when laughing or crying and
difficulty with bladder control at other
times; bother: 0 = not at all to 4 =
extremely
Difficulty with bladder control when laughing or crying = 46% (mean
severity = 1.8 (0.9)); difficulty with bladder control at other times =
58.2% (mean severity = 1.8 (1.0))
Avis et al.,
200436
15 items from BCPT Symptom
Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (1 = not at all to 5 = very
much)
Bladder control - laughing: not at all 74.8%, a little 9.9%, somewhat
8.9%, quite a bit 4.0%, very much 2.5%; bladder control - other: not
at all 73.9%, a little 14.3%, somewhat 6.4%, quite a bit 3.5%, very
much 2.0%; difficulty with bladder control reported as bothersome by
less than 30%
Avis et al.,
200540
15 items from BCPT Symptom
Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (1 = not at all to 5 = very
much)
Difficulty with bladder control (age categories): 25-34 (n=25), 16%;
35-39 (n=41), 22.0%; 40-44 (n=54), 30.2%; 45-50 (n=82), 51.2%;
Total N = 202, 35.3%; p = .0007 - problems increased with age
Chin et al.,
200946
FACT-ES In past 7 days, 4 questions about
urinary tract symptoms since endocrine
therapy; asked to indicate how true a
statement was for them: 0 = not at all
to 4 = very much
Dysuria, none = 87%, mild (1/2) = 10%, moderate/severe (3/4) = 2%;
urinary incontinence, none = 63%, mild (1/2) = 30%,
moderate/severe (3/4) = 3%; urinary urgency, none = 57%, mild (1/2)
= 27%, moderate/severe (3/4) = 14%; increased urinary tract
infections, none = 88%, mild (1/2) = 8%, moderate/severe (3/4) = 4%
Couzi et al.,
199531
Investigator-developed
questionnaire
In last 4 weeks, difficulty with bladder
control
Reported symptom 36% (n = 66 / 183) ; 55% of those reported
symptom severity as mild, 22% as moderate, 23% as severe
Ganz et al.,
200032
7 items adapted from BCPT
Symptom Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (0 = not at all to 4 =
extremely)
Reported “stress urinary incontinence” at baseline = 51% ; 1 reported
urinary incontinence only, 8 reported urinary incontinence and hot
flashes, 27 reported urinary incontinence, hot flashes, and vaginal
dryness; 1 reported urinary incontinence and vaginal dryness; at
baseline urinary scale score for all women = 0.59 (0.82); effect of
intervention on urinary incontinence not reported separately from
menopausal symptoms
Ganz et al.,
200234
Items from BCPT Symptom
Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (0 = not at all to 4 =
extremely)
Frequency of bladder problems when laughing or crying (P = .003)
and at other times (P = .007) increased significantly over time
Ganz et al.,
200335
42 items from BCPT Symptom
Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (0 = not at all to 4 =
extremely)
Approximations from graph: 25 - 34 years = 21%, 35 - 39 years =
20%, 40 - 44 years = 35%, 45 - 51 years = 38%
Greendale et al.,
200133
Items from BCPT Symptom
Checklist
In past 4 weeks, difficulty with bladder
control when laughing or crying,
difficulty with bladder control at other
times; bother: 0 = not at all to 4 =
extremely
Urinary incontinence score mean = 14.8 (20.2), range = 0 to 100
Gupta et al.,
200643
Menopausal Rating Scale with 2xyxweek recall Urinary problems (difficulty urinating,
increased need to urinate, bladder
incontinence); severity: 0 = mild to 4 =
severe
Reported urinary problems = 55%; reported moderate to severe
symptoms = 39%
Land et al.,
200437
17 items from existing
instruments including the BCPT
Symptom Checklist
In past 7 days, bladder problems CMF versus AC: ratio of the odds of reporting being at least’a little
bit bothered by bladder problems = 4.2, 99.8 CI = 1.262, 13.767, p =
.0002
Leining et
al., 200644
16 items from BCPT Symptom
Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (0 = not at all to 4 =
extremely)
Reported loss of bladder control “slightly bothersome or more severe
symptoms:” laughter 26%, other 25%
Morales et
al., 200438
Leuven Menopause Form In past 7 days, did you have frequent
urination (even at night) and urgency,
urine loss when coughing, sneezing
and laughing: not at all; yes, with minor
inconvenience; yes, with moderate
inconvenience; yes, with severe
inconvenience; yes, intolerable
Endocrine therapy naive patients (n = 144) prevalence of urinary
problems at baseline = 28% (n = 41);urinary problems at baseline (n
= 164): tamoxifen first line patients: mild to moderate = 23%;
randomized trial of tamoxifen or letrozole patients: mild to moderate
= 23%; NSAI first-line patients: mild to moderate = 39%; (N)SAI
previous tamoxifen patients: mild to moderate = 25%; urinary
problems at 1 month (n = 163): tamoxifen first line patients: mild to
moderate = 35%; randomized trial of tamoxifen or letrozole patients:
mild to moderate = 28%; NSAI first-line patients: mild to moderate =
43%; (N)SAI previous tamoxifen patients: mild to moderate = 37%;
urinary problems at 3 months (n = 162): tamoxifen first line patients:
mild to moderate = 36%; randomized trial of tamoxifen or letrozole
patients: mild to moderate = 32%; NSAI first-line patients: mild to
moderate = 35%; (N)SAI previous tamoxifen patients: mild to
moderate = 15%*
Oleske et
al., 200439
Symptom Rating Scale (later
modified for use in the National
Surgical Adjuvant Breast and
Bowel Project)
In past 7 days, difficulty in bladder
control
Reported symptoms = 39%: mild 25%, moderate 16%, severe 4%
Schover et
al., 200645
7 items adapted from BCPT
Symptom Checklist
In past 4 weeks, how bothered have
you been by difficulty with bladder
control when laughing or crying / at
other times (0 = not at all to 4 = extremely)
Mean = .67 (1.2) at baseline
Stanton et
al., 200541
42 item from BCPT Symptom
Checklist
In past 4 weeks, difficulty with bladder
control (when laughing or crying);
difficulty with bladder control (at other
times); presence / absence = 1/0;
bother: 0 = not at all to 4 = extremely
Sample 1: 0.52 (.47 to .58); Sample 2: 0.38 (.33 to .43); Sample 3:
0.32 (.28 to .38); Sample 4: 0.40 (.31 to .50)
*

Data also presented for no symptoms and severe to intolerable symptoms

BCPT = Breast Cancer Prevention Trial Symptom Checklist from the National Surgical Adjuvant Breast and Bowel Project

QOL = quality of life

BCS = breast cancer survivors

BC indicates breast cancer

CMF chemotherapy regimen = cyclophosphamide, methotrexate, and 5-fluorouracil

AC chemotherapy regimen = doxorubicin and cyclophosphamide

CI = confidence interval

PCS = Physical Component Summary Score; MCS indicates Mental Component Summary Score

NSAI = non-steroidal aromatase inhibitors

(N)SAI = non-steroidal and steroidal aromatase inhibitors